Skip to main content
. 2007 Jan 4;125(1):50–56. doi: 10.1590/S1516-31802007000100010

Table 2. Therapeutic procedures for hepatorenal syndrome with respective level of evidence and grade of recommendation.

References Treatment Level of evidence Grade of recommendation
Gonwa TA, et al.39 Liver transplant III A
Gines A, et al.41 Paracentesis with (> 5 l) or without albumin III A
Gulberg V, et al.43 and Hadengue A, et al.44 Ornipressin/terlipressin III A
Angeli P, et al.47 Midodrine/octreotide III A
Bennett WM, et al.42 Dopamine IV B
Gines A, et al.41 Albumin III B
Roberts LR, et al.40 Isotonic saline solution IV B
Fevery J, et al.49 and Gines A, et al.50 Prostaglandin analogues - misoprostol IV B
Soper CP, et al.51 Endothelin antagonist IV B
Holt S, et al.52 N-acetylcysteine IV B
Brensing KA, et al.53 Transjugular intrahepatic portosystemic shunt IV B
Moore K35 Dialysis IV B
Mitzner SR, et al.55 Molecular absorbent and recirculating system III B
Solis-Herruzo JA, et al.56 Lumbar sympathetic VI B